比较机器人辅助肾上腺切除术(RA)与腹腔镜肾上腺切除术(LA)治疗嗜铬细胞瘤(PHEO)的临床疗效及安全性。我们对PubMed进行了全面搜索,Cochrane图书馆,和Embase数据库,用于比较RA和LA治疗PHEO的研究,涵盖从数据库开始到2024年1月1日的时期。两名研究人员将独立筛选文献并提取数据,然后使用ReviewManager5.3软件进行荟萃分析。658名患者的6项研究被纳入分析。手术时间[MD=-8.03,95%CI(-25.68,9.62),P>0.05],输血率[OR=1.10,95%CI(0.55,2.19),P>0.05],转化率[OR=0.31,95%CI(0.08,1.12),P>0.05],并发症发生率[OR=0.93,95%CI(0.52,1.70),P>0.05],术中最大SBP[MD=-4.08,95%CI(-10.13,1.97),P>0.05],术中最小SBP[MD=-2.71,95%CI(-9.60,4.18),RA和LA患者中P>0.05。然而,与接受LA的患者相比,RA患者估计失血较少[MD=-37.72,95%CI(-64.11,-11.33),P<0.05],住院时间较短[MD=-0.43,95%CI(-0.65,-0.21)P<0.05]。与LA相比,RA在某些方面具有更高的优势。RA是可行的,安全,和PHEO的可比治疗方案。
To compare the clinical efficacy and safety of robot-assisted adrenalectomy (RA) and laparoscopic adrenalectomy (LA) for
pheochromocytoma (PHEO). We conducted a comprehensive search of PubMed, the Cochrane Library, and Embase databases for studies comparing RA and LA treatment for PHEO, covering the period from database inception to January 1, 2024. Two researchers will independently screen literature and extract data, followed by meta-analysis using
Review Manager 5.3 software. Six studies with 658 patients were included in the analysis. There were no significant differences in operation time [MD = -8.03, 95% CI (-25.68,9.62), P > 0.05], transfusion rate [OR = 1.10, 95% CI (0.55, 2.19) , P > 0.05], conversion rate [OR = 0.31, 95% CI (0.08, 1.12), P > 0.05], complication rate [OR = 0.93, 95% CI (0.52, 1.70), P > 0.05], Intraoperative max SBP [MD = -4.08, 95% CI (-10.13,1.97), P > 0.05], Intraoperative min SBP [MD = -2.71, 95% CI (-9.60,4.18), P > 0.05] among patients undergoing RA and LA. However, compared with patients who underwent LA, patients who underwent RA had less estimated blood loss [MD = -37.72, 95% CI (-64.11,-11.33), P < 0.05], a shorter length of hospital stay [MD = -0.43, 95% CI (-0.65,-0.21) P < 0.05]. RA has higher advantages in some aspects compared to LA. RA is a feasible, safe, and comparable treatment option for PHEO.